Loading...
Adverse events reporting in stage III NSCLC trials investigating surgery and radiotherapy
BACKGROUND: Current treatment options for stage III non-small cell lung cancer (NSCLC) consist of different combinations of chemotherapy, surgery, radiotherapy and immunotherapy. Treatment choices are highly individual decisions, in which adverse events (AEs) are relevant for decision-making. This s...
Na minha lista:
| Udgivet i: | ERJ Open Res |
|---|---|
| Main Authors: | , , , , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
European Respiratory Society
2020
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7487347/ https://ncbi.nlm.nih.gov/pubmed/32963993 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1183/23120541.00010-2020 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|